Biogen Inc. (ETR:IDP)
126.10
-3.45 (-2.66%)
Oct 10, 2025, 5:35 PM CET
Biogen Market Cap
Biogen has a market cap or net worth of €18.49 billion as of October 10, 2025. Its market cap has decreased by -25.10% in one year.
Market Cap
18.49B
Enterprise Value
21.79B
Revenue
8.51B
Ranking
n/a
PE Ratio
14.19
Stock Price
€126.10
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 126.71M to 18.49B, an increase of 14,489.66%. That is a compound annual growth rate of 15.74%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 18.49B | -14.11% |
Dec 31, 2024 | 21.52B | -36.55% |
Dec 29, 2023 | 33.92B | -9.09% |
Dec 30, 2022 | 37.31B | 20.41% |
Dec 31, 2021 | 30.99B | 0.60% |
Dec 31, 2020 | 30.80B | -35.44% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Siemens Healthineers AG | 52.54B |
Merck KGaA | 50.48B |
Bayer Aktiengesellschaft | 27.49B |
Fresenius SE & Co. KGaA | 26.87B |
Fresenius Medical Care AG | 13.48B |
Sartorius Aktiengesellschaft | 13.36B |
Fielmann Group AG | 4.17B |
Carl Zeiss Meditec AG | 3.74B |